A Study Assessing Esophageal Function and Remodeling With Dupilumab Compared With Placebo for 24 Weeks Followed by 104 Weeks Open Label in Adult Participants With EoE (REMOdeling With Dupilumab in Eosinophilic Esophagitis Long-term Trial)

PHASE4Active, not recruitingINTERVENTIONAL
Enrollment

64

Participants

Timeline

Start Date

November 29, 2023

Primary Completion Date

November 11, 2025

Study Completion Date

February 1, 2028

Conditions
Eosinophilic Oesophagitis
Interventions
DRUG

Dupilumab

Subcutaneous injection (SC) as per protocol

DRUG

Placebo

SC injection as per protocol

Trial Locations (30)

8091

Investigational Site Number : 7560002, Zurich

8620

Investigational Site Number : 7560001, Wetzikon

19104

Penn Medicine: University of Pennsylvania Health System- Site Number : 8400010, Philadelphia

27514

University of North Carolina at Chapel Hill- Site Number : 8400007, Chapel Hill

32256

Borland Groover Clinic- Site Number : 8400016, Jacksonville

44195

Cleveland Clinic - Cleveland- Site Number : 8400009, Cleveland

52242

University of Iowa- Site Number : 8400006, Iowa City

55905

Mayo Clinic Hospital Rochester- Site Number : 8400008, Rochester

60026

GI Alliance - Glenview- Site Number : 8400012, Glenview

60031

Illinois Gastroenterology Group- Site Number : 8400004, Gurnee

60611

Northwestern University- Site Number : 8400003, Chicago

76063

GI Alliance - Mansfield- Site Number : 8400017, Mansfield

77087

Private Practice - Dr. Martin Yudovich- Site Number : 8400015, Houston

83706

Treasure Valley Medical Research- Site Number : 8400018, Boise

92563

United Gastroenterologists - Murrieta- Site Number : 8400001, Murrieta

94143

University of California San Francisco - Parnassus Heights- Site Number : 8400020, San Francisco

3104802

Investigational Site Number : 3760006, Haifa

3109601

Investigational Site Number : 3760002, Haifa

6423906

Investigational Site Number : 3760003, Tel Aviv

9103102

Investigational Site Number : 3760005, Jerusalem

9112001

Investigational Site Number : 3760004, Jerusalem

01655

University of Massachusetts Chan Medical School- Site Number : 8400019, Worcester

41825-010

Itaigara Memorial - Hospital Dia- Site Number : 0760005, Salvador

90610-000

Hospital São Lucas da PUCRS - Porto Alegre - Avenida Ipiranga- Site Number : 0760006, Porto Alegre

13010-001

Clínica Loema - Unidade I- Site Number : 0760007, Campinas

18040-425

Clinica de Alergia Martti Antila- Site Number : 0760001, Sorocaba

01323-020

Hospital Alemao Oswaldo Cruz - São Paulo- Site Number : 0760003, São Paulo

V5Z 1M9

Investigational Site Number : 1240006, Vancouver

V6Z 2K5

Investigational Site Number : 1240004, Vancouver

H4A 3T2

Investigational Site Number : 1240002, Montreal

Sponsors

Lead Sponsor

All Listed Sponsors
collaborator

Regeneron Pharmaceuticals

INDUSTRY

lead

Sanofi

INDUSTRY